Technology ID
E-009-2018-0

Encapsulated <em>Streptococcus</em> Compositions and Methods for Pneumococcal Vaccine, Probiotic, and Diagnostic Assay Development

Linked ID
TAB-3364
Inventors
Bernard Beall (CDC)
Cynthia Whitney (CDC)
Fabiana Pimenta (CDC)
Fernanda Lessa (CDC)
Jennifer Milucky (CDC)
Maria Da Gloria Carvalho (CDC)
Monica Farley (Emory University)
Lead Inventors
Cynthia Whitney (CDC)
Co-Inventors
Bernard Beall (CDC)
Fabiana Pimenta (CDC)
Fernanda Lessa (CDC)
Jennifer Milucky (CDC)
Maria Da Gloria Carvalho (CDC)
Monica Farley (Emory University)
ICs
CDC
Commercial Applications
  • Novel live vaccine or vaccine component to prevent against Streptococcus pneumoniae
  • Therapeutic, probiotic or preventive for other pneumococcal conditions (e.g., ear infections, meningitis, and bacteremia)
  • Vaccine-related assays
  • Diagnostic assays
Competitive Advantages
  • May be prepared in a variety of dosage forms such as solution, solid or powdered (e.g., lyophilized) form
  • Easily adaptable to kit form
  • Vaccine compositions may protect against multiple pneumococcal organisms or be tailored for specific serotypes affecting a particular population
  • May address drawbacks of currently available S. pneumoniae vaccines where certain populations do not respond optimally to vaccine antigens

Request More Info

Licensing Contact